Back
LYRA
Lyra Therapeutics Inc
🇺🇸 NYSE/NASDAQ
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
-2.12%
Annual Growth
5 years average annual capital growth
🌏
2
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Lyra Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of therapies for the localized treatment of patients with chronic rhinosinusitis (CRS). The Company is developing therapies for CRS, a prevalent inflammatory disease of the paranasal sinuses that leads to debilitating symptoms and significant morbidities. LYR-210, the Company’s lead product, is a bioabsorbable nasal implant designed to be administered in a simple, in-office procedure and is intended to deliver six months of continuous anti-inflammatory drug therapy to the sinonasal passages for the treatment of CRS with a single administration. LYR-210, being evaluated in the ENLIGHTEN Phase III clinical program, is intended for patients with and without nasal polyps. The drug embedded within LYR-210 is mometasone furoate (MF).
📈 Performance
Price History*
-43.49%
1M
1Y
All Time
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$10.45
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in LYRA
2
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
6 days
💵 Average investment amount
$845
⏰ Last time a customer invested in LYRA
13 days
LYRA investor breakdown
💵 Income of investors
More than 200k
150k - 200k
50%
100k - 150k
50%
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
50%
26 - 34
35 - 90
50%
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in LYRA also invest in...
🙌 Performance (5Yr p.a)
281.95%
📊 Share price
$143.85 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
18.18%
📊 Share price
$547.72 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
26.84%
📊 Share price
$128.24 USD
📈 HIGH PRICE GROWTH
Want more shares? Try these...
